Intra-individual variability of high-sensitivity C-reactive protein: Age-related variation over time in Japanese subjects

Circulation Journal

Volumn 70, Issue 5, 2006, Pages 559-563

  Nasermoaddeli, Ali ^a   Sekine, Michikazu ^a   Kagamimori, Sadanobu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Age; C reactive protein; Gender; Japan; Variation

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORRELATION COEFFICIENT; FEMALE; FOLLOW UP; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; OBSERVER VARIATION; PROTEIN BLOOD LEVEL; RELIABILITY; REPRODUCIBILITY; RISK ASSESSMENT; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; JAPAN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEX FACTORS;

EID: 33646088348     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.70.559     Document Type: Article

References (23)

1. Blake GJ, Ridker PM. Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med 2002; 252: 283-294.
2. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003; 107: 363-369.
3. Ridker PM. High-sensitivity C-reactive protein and cardiovascular risk: Rationale for screening and primary prevention. Am J Cardiol 2003; 92(Suppl): 17K-22K.
4. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347: 1557-1565.
5. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: The Framingham study. Stroke 2001; 32: 2575-2579.
6. Hong YJ, Jeong MH, Lim SY, Lee SR, Kim KH, Sohn IS, et al. Elevated preprocedural high-sensitivity C-reactive protein levels are associated with neointimal hyperplasia and restenosis development after successful coronary artery stenting. Circ J 2005; 69: 1477-1483.
7. Libby P, Ridker PM. Novel inflammatory markers of coronary risk: Theory versus practice. Circulation 1999; 100: 1148-1150.
8. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-454.
9. Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: Implications for reference intervals and epidemiologic applications. Clin Chem 1997; 43: 52-58.
10. de Maat MP, de Bart AC, Hennis BC, Meijer P, Havelaar AC, Mulder PG, et al. Interindividual and intra-individual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris. Arterioscler Thromb Vasc Biol 1996; 16: 1156-1162.
11. Sakkinen PA, Macy EM, Callas PW, Cornell ES, Hayes TE, Kuller LH, et al. Analytical and biological variability in measures of hemostasis, fibrinolysis, and inflammation: Assessment and implications for epidemiology. Am J Epidemiol 1999; 149: 261-267.
12. Nasermoaddeli A, Sekine M, Kagamimori S. Gender differences in associations of C-reactive protein with atherosclerotic risk factors and psychosocial characteristics in Japanese civil servants. Psychosom Med 2006; 68: 58-63.
13. Nakanishi N, Shiraishi T, Wada M. C-reactive protein concentration is more strongly related to metabolic syndrome in women than in men: The Minoh Study. Circ J 2005; 69: 386-391.
14. Bland JM, Altman DG. Measurement error. BMJ 1996; 312: 1654.
15. Bland JM, Altman DG. Measurement error and correlation coefficients. BMJ 1996; 313: 41-42.
16. Yamada S, Gotoh T, Nakashima Y, Kayaba K, Ishikawa S, Nago N, et al. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population. Am J Epidemiol 2001; 153: 1183-1190.
17. Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E. Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation 1999; 100: 230-235.
18. Koenig W, Sund M, Frohlich M, Lowel H, Hutchinson WL, Pepys MB. Refinement of the association of serum C-reactive protein concentration and coronary heart disease risk by correction for within-subject variation over time: The Monica Augsburg studies, 1984 and 1987. Am J Epidemiol 2003; 158: 357-364.
19. Ockene IS, Matthews CE, Rifai N, Ridker PM, Reed G, Stanek E. Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem 2001; 47: 444-450.
20. Kayaba K, Ishikawa S, Gotoh T, Nago N, Kajii E, Nakamura Y, et al. Five-year intra-individual variability in C-reactive protein levels in a Japanese population-based study: The Jichi Medical School Cohort Study at Yamato, 1993-1998. Jpn Circ J 2000; 64: 303-308.
21. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, et al. Low grade inflammation and coronary heart disease: Prospective study and updated meta-analysis. BMJ 2000; 321: 199-204.
22. Meier-Ewert HK, Ridker PM, Rifai N, Price N, Dinges DF, Mullington JM. Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin Chem 2001; 47: 426-430.
23. Frohlich M, Sund M, Thorand B, Hutchinson WL, Pepys MB, Koenig W. Lack of seasonal variation in C-reactive protein. Clin Chem 2002; 48: 575-577.